Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker CADL
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Paul Peter Tak Director, Officer | CADL Candel Therapeutics, Inc. | 280,245 | $3.4M | 10b5-1 | Sep 10, 2026 | Form 4 ↗ 1 day later · 280,245 shares | Form 144 ↗ |
| Aug 17, 2026 | Seshu Tyagarajan Officer | CADL Candel Therapeutics, Inc. | 7,000 | $82.0K | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 2 days later · 7,000 shares | Form 144 ↗ |
| Jun 29, 2026 | Seshu P Tyagarajan Officer | CADL Candel Therapeutics, Inc. | 7,000 | $68.5K | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 2 days later · 7,000 shares | Form 144 ↗ |
| Jun 29, 2026 | Francesca Barone Officer | CADL Candel Therapeutics, Inc. | 23,447 | $229.5K | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 2 days later · 23,447 shares | Form 144 ↗ |
| Jun 30, 2025 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 3,593 | $17.6K | 10b5-1 | Jun 30, 2025 | Form 4 ↗ 2 days later · 781 shares | Form 144 ↗ |
| Mar 18, 2025 | Francesca Barone Officer | CADL Candel Therapeutics, Inc. | 32,146 | $283.8K | 10b5-1 | Mar 18, 2025 | Form 4 ↗ 2 days later · 32,146 shares | Form 144 ↗ |
| Mar 18, 2025 | Paul Peter Tak Director, Officer | CADL Candel Therapeutics, Inc. | 74,106 | $654.4K | 10b5-1 | Mar 18, 2025 | Form 4 ↗ 2 days later · 26,172 shares | Form 144 ↗ |
| Mar 18, 2025 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 45,316 | $400.1K | 10b5-1 | Mar 18, 2025 | Form 4 ↗ 2 days later · 45,316 shares | Form 144 ↗ |
| Mar 17, 2025 | Seshu Tyagarajan Officer | CADL Candel Therapeutics, Inc. | 31,278 | $273.7K | 10b5-1 | Mar 17, 2025 | Form 4 ↗ 2 days later · 31,278 shares | Form 144 ↗ |
| Mar 17, 2025 | Charles Schoch Officer | CADL Candel Therapeutics, Inc. | 5,000 | $43.8K | 10b5-1 | Mar 17, 2025 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Jan 15, 2025 | Tyagarajan Seshu Officer | CADL Candel Therapeutics, Inc. | 13,177 | $103.3K | — | Jan 15, 2025 | Form 4 ↗ 2 days later · 14,322 shares | Form 144 ↗ |
| Jan 15, 2025 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 9,564 | $75.2K | — | Jan 15, 2025 | Form 4 ↗ 2 days later · 10,428 shares | Form 144 ↗ |
| Jan 15, 2025 | Barone Francesca Officer | CADL Candel Therapeutics, Inc. | 12,452 | $97.6K | — | Jan 15, 2025 | Form 4 ↗ 2 days later · 13,534 shares | Form 144 ↗ |
| Jan 15, 2025 | Charles Schoch Officer | CADL Candel Therapeutics, Inc. | 8,751 | $68.6K | — | Jan 15, 2025 | Form 4 ↗ 2 days later · 9,511 shares | Form 144 ↗ |
| Jan 15, 2025 | Paul Peter Tak Officer, Director | CADL Candel Therapeutics, Inc. | 19,970 | $156.6K | — | Jan 15, 2025 | Form 4 ↗ 2 days later · 21,704 shares | Form 144 ↗ |
| Jan 8, 2025 | Tyagarajan Seshu Officer | CADL Candel Therapeutics, Inc. | 14,297 | $119.4K | — | Jan 8, 2025 | Form 4 ↗ 2 days later · 14,545 shares | Form 144 ↗ |
| Jan 8, 2025 | Paul Peter Tak Officer, Director | CADL Candel Therapeutics, Inc. | 20,811 | $173.8K | — | Jan 8, 2025 | Form 4 ↗ 2 days later · 21,172 shares | Form 144 ↗ |
| Jan 8, 2025 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 10,614 | $88.6K | — | Jan 8, 2025 | Form 4 ↗ 2 days later · 10,799 shares | Form 144 ↗ |
| Jan 8, 2025 | Barone Francesca Officer | CADL Candel Therapeutics, Inc. | 13,440 | $112.2K | — | Jan 8, 2025 | Form 4 ↗ 2 days later · 13,673 shares | Form 144 ↗ |
| Jan 8, 2025 | Charles Schoch Officer | CADL Candel Therapeutics, Inc. | 9,801 | $81.8K | — | Jan 8, 2025 | Form 4 ↗ 2 days later · 9,971 shares | Form 144 ↗ |
| Nov 29, 2024 | Tyagarajan Seshu Officer | CADL Candel Therapeutics, Inc. | 18,548 | $91.8K | — | Nov 29, 2024 | Form 4 ↗ 4 days later · 20,392 shares | Form 144 ↗ |
| Nov 29, 2024 | Paul Peter Tak Officer, Director | CADL Candel Therapeutics, Inc. | 44,433 | $219.9K | — | Nov 29, 2024 | Form 4 ↗ 4 days later · 48,847 shares | Form 144 ↗ |
| Nov 29, 2024 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 12,675 | $62.7K | — | Nov 29, 2024 | Form 4 ↗ 4 days later · 13,935 shares | Form 144 ↗ |
| Nov 29, 2024 | Barone Francesca Officer | CADL Candel Therapeutics, Inc. | 20,085 | $99.4K | — | Nov 29, 2024 | Form 4 ↗ 4 days later · 22,081 shares | Form 144 ↗ |
| Sep 23, 2024 | Aguilar-Cordova Estuardo Director | CADL Candel Therapeutics, Inc. | 28,480 | $199.4K | — | Sep 23, 2024 | Form 4 ↗ 10 days later · 35,002 shares | Form 144 ↗ |
| Sep 13, 2024 | Aguilar-Cordova Estuardo Director | CADL Candel Therapeutics, Inc. | 28,840 | $187.5K | — | Sep 13, 2024 | Form 4 ↗ 20 days later · 35,002 shares | Form 144 ↗ |
| Jul 17, 2024 | Tyagarajan Seshu Officer | CADL Candel Therapeutics, Inc. | 13,164 | $96.0K | — | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | Paul Peter Tak Officer, Director | CADL Candel Therapeutics, Inc. | 19,970 | $145.6K | — | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | Charles Schoch Officer | CADL Candel Therapeutics, Inc. | 8,761 | $63.9K | — | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 9,640 | $70.3K | — | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | Barone Francesca Officer | CADL Candel Therapeutics, Inc. | 12,455 | $90.8K | — | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 11, 2024 | Tyagarajan Seshu Officer | CADL Candel Therapeutics, Inc. | 13,117 | $77.7K | — | Jul 11, 2024 | — | Form 144 ↗ |
| Jul 11, 2024 | Paul Peter Tak Officer, Director | CADL Candel Therapeutics, Inc. | 19,970 | $118.2K | — | Jul 11, 2024 | — | Form 144 ↗ |
| Jul 11, 2024 | Charles Schoch Officer | CADL Candel Therapeutics, Inc. | 8,754 | $51.8K | — | Jul 11, 2024 | — | Form 144 ↗ |
| Jul 11, 2024 | William Garrett Nichols Officer | CADL Candel Therapeutics, Inc. | 9,613 | $56.9K | — | Jul 11, 2024 | — | Form 144 ↗ |
| Jul 11, 2024 | Barone Francesca Officer | CADL Candel Therapeutics, Inc. | 12,443 | $73.7K | — | Jul 11, 2024 | — | Form 144 ↗ |
36 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:12 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances